★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

Established in 1999

News/Compliance & Enforcement/OIG Determines That a Program to Provide Free Eye Drops to Eligible Patients Undergoing a Particular Treatment is Not Subject to Sanctions
Expert Opinion·Compliance & Enforcement Brief

OIG Determines That a Program to Provide Free Eye Drops to Eligible Patients Undergoing a Particular Treatment is Not Subject to Sanctions

PA
PubK AdminJanuary 11, 2022 · 1 min read
🔒 Members Only

On December 6, 2021, OIG issued an advisory opinion to a pharmaceutical manufacturer regarding its arrangement to provide free eye drops to patients who are prescribed one of the manufacturer’s drugs which is known to cause keratopathy (changes to the corneal surface) as a side effect of treatment.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year
Become a Member
Sign In
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.